Shiva Nemati; Ebrahim Shahbazi; Mehdi Hesaraki; Sahar Kiani; Reza Haji Hossein
Volume 5, Issue 2 , December 2016, , Pages 35-51
Abstract
Spinal cord injury (SCI) is a devastating condition producing great personal and societal costs and for which there is no effective treatment. Stem cell transplantation is a promising therapeutic strategy, though much preclinical and clinical research work remains. Here, we briefly describe SCI epidemiology, ...
Read More
Spinal cord injury (SCI) is a devastating condition producing great personal and societal costs and for which there is no effective treatment. Stem cell transplantation is a promising therapeutic strategy, though much preclinical and clinical research work remains. Here, we briefly describe SCI epidemiology, pathophysiology, and transplantation trial in human developments, including termination of the first human embryonic stem cell experimental and clinical stem cell strategies. Research in stem cell biology and cell reprogramming is rapidly advancing, with the hope of moving stem cell therapy closer to helping people with SCI. We examine issue important for clinical translation and provide a commentary on recent SCI.
